Navigation Links
CORD:USE Cord Blood Bank Receives Prestigious Accreditation from the Foundation for the Accreditation of Cellular Therapy
Date:1/22/2009

ORLANDO, Fla., Jan. 22 /PRNewswire/ -- CORD:USE Cord Blood Bank is honored to announce that it has been accredited by the Foundation for the Accreditation of Cellular Therapy ("FACT"). CORD:USE is a leading public cord blood bank that specializes in the collection, processing, storage and distribution of donated cord blood. Cord blood has already been used for transplantation in more than 14,000 patients with over 70 life-threatening diseases such as leukemia, lymphoma, thalassemia, and sickle cell anemia.

"The Accreditation by FACT is an important milestone for CORD:USE," says Dr. Edward Guindi, President and CEO of CORD:USE Cord Blood Bank. "Obtaining FACT Accreditation for cord blood collection, processing, testing, banking, selection and release of unrelated allogeneic cord blood units validates the high quality procedures which CORD:USE and our world-class team utilize. This accreditation gives additional assurance to transplant physicians when choosing our units for their patients."

FACT is considered by many transplanters to be the premier accreditation organization in the cord blood banking industry. FACT is a non-profit, voluntary organization that develops, maintains and updates comprehensive standards for all aspects of cord blood collection, processing and transplantation. The process includes an examination and inspection from international panels of cord blood experts and at least one transplant physician. The examination team reviews all aspects of the cord blood banking process. Only those companies with consistent, well-documented processes that meet the standards developed by FACT in all areas are eligible for accreditation.

"We are extremely proud to be one of the elite cord blood banks worldwide who has met the stringent processes standards required for FACT accreditation and that provides the highest quality cord blood units for patients in need of potentially life-saving transplants," says Dr. Guindi.

About CORD:USE Cord Blood Bank

CORD:USE Cord Blood Bank, headquartered in Orlando, Florida, is creating a large, ethnically diverse, high quality inventory of available cord blood stem cell units for the many patients in need of a potentially life-saving transplant. CORD:USE has entered into agreements with hospitals across the country to provide mothers the option to donate their babies' cord blood. CORD:USE makes these cord blood units available to transplanters throughout the country and around the world, as a critical component in their patients' treatment. CORD:USE lists all of its units on the National Marrow Donor Program's Registry. For more information, please visit www.corduse.com.


'/>"/>
SOURCE CORD:USE Cord Blood Bank
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Specific antagonism lowers blood pressure
2. Restricting Blood Flow May Help Heart Bypass Patients
3. FDA Updates Prescription Guidelines for Blood Thinner
4. Doctors Often Miss High Blood Pressure in Kids
5. Back to School Means Return of School Blood Drives
6. Blood-flow detector software show promise in preventing brain damage
7. FDA Approves New Roche West Nile Virus Blood Screening Test
8. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
9. Laser blasts viruses in blood
10. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
11. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... ... seeking public support to bring their novel lifesaving device for the everyday use ... with medical-grade sensors, specially designed to read a child’s vital signs, and detect ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... are expected to be diagnosed globally; approximately 25,000 of them will be malignant.(1) ... greater use of this type of healthcare model in the diagnosis and treatment ...
(Date:4/24/2017)... ... April 24, 2017 , ... Come to PAINWeekEnd (PWE) Tampa on May 20 ... an educational and exciting 2-day program. , An attendee at a recent PAINWeekEnd ... approach patients” about the course entitled Ain't Misbehavin': Decreasing and Managing Pain Patient Aberrant ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Learning to Use Your SPIRITUAL COMPASS To Navigate ... Use Your SPIRITUAL COMPASS To Navigate Life Issues” is the creation of published author, ... the Board of Directors for CONTACT USA, and former member of the American Association ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... the development of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic ... manufacture its ANCD BRAIN device as the product advances towards regulatory and clinical ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/18/2017)... April 18, 2017  Cardinal Health (NYSE: ... fiscal 2017 earnings per share (EPS) guidance and providing ... is in conjunction with this morning,s announcement of the ... and Nutritional Insufficiency businesses. Cardinal Health now ... will be at the bottom of its previous guidance ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, 2017 ... ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, and Cameron ... announced the signing of a three-year exclusive sales ... deploy a dedicated sales team to introduce Imprimis, ... primarily focused in 13 states in the U.S. ...
Breaking Medicine Technology: